Landscape of clinically actionable mutations in breast cancer ‘A cohort study’

Landscape of clinically actionable mutations in breast cancer ‘A cohort study’

Breast cancer (BC) is a heterogeneous disease. Numerous chemotherapeutic agents are available for early stage or advanced/metastatic breast cancer to provide maximum benefit with minimum side effects. However, the clinical outcome of patients with the same clinical and pathological characteristics a...

Full description

Bibliographic Details
Main Authors: Mithua Ghosh, Radheshyam Naik, Sheela Mysore Lingaraju, Sridhar Papaiah Susheela, Shekar Patil, Gopinath Kodaganur Srinivasachar, Satheesh Chiradoni Thungappa, Krithika Murugan, Srinivas Belagutty Jayappa, Somorat Bhattacharjee, Nalini Rao, Mahesh Bandimegal, Roopesh Krishnappa, Shashidhara Haragadde Poppareddy, Krishna Chennagiri Raghavendrachar, Yogesh Shivakumar, Sunitha Nagesh, Ramya Kodandapani, Ashwini Rajan, Urvashi Bahadur, Pooja Agrawal, Veena Ramaswamy, Tejaswini Bangalore Nanjaiah, Sateesh Kunigal, Shanmukh Katragadda, Ashwini Manjunath, Amritanshu Ram, Basavalinga S. Ajaikumar
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Translational Oncology
Subjects:
Breast cancer
Next generation sequencing
NGS
Genetic profiling
Somatic mutations: PIK3CA
Signalling pathway
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523320303697

Internet

http://www.sciencedirect.com/science/article/pii/S1936523320303697

Similar Items